Go Back

Company or ticker...

Legend Biotech

Legend Biotech develops cell therapies that use genetically modified immune cells to fight cancer, including treatments for multiple myeloma.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

LEGN

3.7B

0.0

n/a

-12.52%

Key Facts

M. Cap

PS

PE

YTD

3.7B

0.0

n/a

-12.52%

10MA

20MA

50MA

200MA

$LEGN

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now